Eileen Axibal, MD
MOHS-Micrographic Surgery · Grand Rapids, MINPI 1154732386
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 91.6% of the total across 64 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 16 manufacturers reported payments, led by AbbVie at 25.0% of the total. Reporting peaked in 2022 at $503 and has fallen 52.7% since, to $238 in 2025. That places this record below the midpoint for mohs-micrographic surgery clinicians in MI, where the typical reported total is $1,792.
Across 64 payments — averaging $23.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$369
- Johnson & Johnson$267
- Regeneron Healthcare Solutions, Inc.$178
- Sanofi$128
- Incyte Corporation$122
- Amgen$108
- plus $301 from 10 others
What the payments were for
- Food & beverage$1,34992%
- Education$1238%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 17 | $369 |
| Johnson & Johnson | 10 | $267 |
| Regeneron Healthcare Solutions, Inc. | 6 | $178 |
| Sanofi | 5 | $128 |
| Incyte Corporation | 5 | $122 |
| Amgen | 3 | $108 |
| Genentech USA, Inc. | 4 | $66 |
| Pfizer | 3 | $60 |
| Kyowa Kirin, Inc. | 2 | $37 |
| DUSA Pharmaceuticals, Inc. | 2 | $32 |
| Helsinn Therapeutics (U.S.), Inc. | 2 | $25 |
| Organogenesis Inc. | 1 | $24 |
| E.r. Squibb & Sons, L.L.C. | 1 | $16 |
| Arcutis Biotherapeutics, Inc. | 1 | $15 |
| Journey Medical Corporation | 1 | $14 |
| Lilly USA, LLC | 1 | $12 |
How this compares
$1,472 in reported general payments places this provider in the 35th percentile of 30 mohs-micrographic surgery providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clobetasol Propionate | 31 | $870 |
| Mupirocin | 60 | $390 |
| Doxycycline Hyclate | 70 | $375 |
| Triamcinolone Acetonide | 23 | $259 |
| Cephalexin | 47 | $187 |
Paid to pharmacies, not to this prescriber.
Other mohs-micrographic surgery in Grand Rapids
- Adam AsarchGrand Rapids$2K
- John MinerGrand Rapids$948
- Bryan SofenRoyal Oak$35K
- David OzogDetroit$22K
- Michael WhitworthWyandotte$13K
- David ByrdRochester Hills$10K
- Ryan JonesPortage$9K
- Abraham AbdulhakDearborn$8K
- Lindsay SklarWest Bloomfield$6K
- Luke NicholasRockford$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.